Literature DB >> 2179835

Water, electrolyte, and endocrine homeostasis in infants with bronchiolitis.

D Gozal1, A A Colin, M Jaffe, Z Hochberg.   

Abstract

Twenty-two of 23 consecutive infants with bronchiolitis, 5.5 +/- 3.5 mo of age, showed a 1.9 +/- 1.4% increase in body weight, increased urinary osmolality of 737 +/- 193 mmol/L with low plasma osmolality of 275 +/- 4 mmol/L, and markedly elevated plasma antidiuretic hormone (ADH) levels of 114 +/- 225 pg/mL. Increased ADH, which usually suppresses plasma renin activity, was associated with increased plasma renin activity of 11-55 ng angiotensin 1/mL/h (normal for age less than 10 ng angiotensin 1/mL/h). Hyperaldosteronism was evident from the low fractional excretion of sodium of 0.27 +/- 0.2% and high fractional excretion of potassium of 21 +/- 15%. Serum sodium concentrations were normal. All of the pathologic findings returned to normal when the bronchiolitis subsided. A control group of 10 infants with nonrespiratory febrile illness did not show any of the above abnormalities. Thus, bronchiolitis of infancy is characterized by both increased ADH secretion and hyperreninemia with secondary hyperaldosteronism, which induce water retention but counterbalance each other with respect to serum sodium. Increased ADH secretion as well as increased plasma renin activity are not "inappropriate," but rather suggest a response to the perception of hypovolemia by intrathoracic receptors. We therefore conclude that the clinical management of bronchiolitis requires close monitoring of body wt and plasma osmolality-urinary osmolality relationship; serum sodium levels may be misleading.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2179835     DOI: 10.1203/00006450-199002000-00023

Source DB:  PubMed          Journal:  Pediatr Res        ISSN: 0031-3998            Impact factor:   3.756


  12 in total

Review 1.  "Drink plenty of fluids": a systematic review of evidence for this recommendation in acute respiratory infections.

Authors:  Michelle P B Guppy; Sharon M Mickan; Chris B Del Mar
Journal:  BMJ       Date:  2004-02-28

2.  Lower airway disease caused by respiratory syncytial virus.

Authors:  R Aggarwal
Journal:  Indian J Pediatr       Date:  1998 May-Jun       Impact factor: 1.967

3.  Excessive secretion of antidiuretic hormone in infections with respiratory syncytial virus.

Authors:  H A van Steensel-Moll; J A Hazelzet; E van der Voort; H J Neijens; W H Hackeng
Journal:  Arch Dis Child       Date:  1990-11       Impact factor: 3.791

4.  The neuroendocrine stress response and severity of acute respiratory syncytial virus bronchiolitis in infancy.

Authors:  Robert C Tasker; Michael F E Roe; David M Bloxham; Deborah K White; Robert I Ross-Russell; D Roddy O'Donnell
Journal:  Intensive Care Med       Date:  2004-11-06       Impact factor: 17.440

Review 5.  Advising patients to increase fluid intake for treating acute respiratory infections.

Authors:  Michelle Pb Guppy; Sharon M Mickan; Chris B Del Mar; Sarah Thorning; Alexander Rack
Journal:  Cochrane Database Syst Rev       Date:  2011-02-16

6.  Clinical settings and vasopressin function in hyponatraemic children.

Authors:  M Gerigk; M Bald; F Feth; W Rascher
Journal:  Eur J Pediatr       Date:  1993-04       Impact factor: 3.183

7.  Hyponatremic seizure associated with acute respiratory infection.

Authors:  Yoshitaka Iwazu; Sumiko Honma; Genro Fujisawa; Kiyoko Uki; Ichiro Yanaka; Yoshiaki Sato; Mitsunobu Murata; Eiji Kusano; Yasushi Asano
Journal:  Clin Exp Nephrol       Date:  2007-09-28       Impact factor: 2.801

Review 8.  Extrapulmonary manifestations of severe respiratory syncytial virus infection--a systematic review.

Authors:  Michael Eisenhut
Journal:  Crit Care       Date:  2006       Impact factor: 9.097

Review 9.  Recent advances in the management of acute bronchiolitis.

Authors:  Claudia Ravaglia; Venerino Poletti
Journal:  F1000Prime Rep       Date:  2014-11-04

Review 10.  Acute bronchiolitis in infants, a review.

Authors:  Knut Øymar; Håvard Ove Skjerven; Ingvild Bruun Mikalsen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2014-04-03       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.